These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26398827)

  • 21. Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review.
    Pillot G; Siegel BA; Govindan R
    J Thorac Oncol; 2006 Feb; 1(2):152-9. PubMed ID: 17409845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    Weber WA; Gatsonis C; Siegel B
    J Nucl Med; 2015 Oct; 56(10):1636. PubMed ID: 26251423
    [No Abstract]   [Full Text] [Related]  

  • 23. FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
    Kwon W; Howard BA; Herndon JE; Patz EF
    J Thorac Oncol; 2015 Jun; 10(6):897-902. PubMed ID: 25811445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
    de Jong WK; van der Heijden HF; Pruim J; Dalesio O; Oyen WJ; Groen HJ
    J Thorac Oncol; 2007 Nov; 2(11):1007-12. PubMed ID: 17975491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
    Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postsurgical atypical F-18 fluorodeoxyglucose positron emission tomography uptake.
    Dubroff JG; Alavi A; Friedberg JS; Cengel KA
    Clin Nucl Med; 2009 Nov; 34(11):808-10. PubMed ID: 19851183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    Hoekstra CJ; Stroobants SG; Smit EF; Vansteenkiste J; van Tinteren H; Postmus PE; Golding RP; Biesma B; Schramel FJ; van Zandwijk N; Lammertsma AA; Hoekstra OS
    J Clin Oncol; 2005 Nov; 23(33):8362-70. PubMed ID: 16293866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.
    Nair VS; Krupitskaya Y; Gould MK
    J Thorac Oncol; 2009 Dec; 4(12):1473-9. PubMed ID: 19887967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Value of Establishing the Quantitative Accuracy of PET/CT Imaging.
    Kinahan PE; Mankoff DA; Linden HM
    J Nucl Med; 2015 Aug; 56(8):1133-4. PubMed ID: 26089552
    [No Abstract]   [Full Text] [Related]  

  • 31. The standardize uptake value: light and shade of positron emission tomography.
    Bertolaccini L; Rizzardi G; Terzi A; Bianchi A
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):969. PubMed ID: 21659322
    [No Abstract]   [Full Text] [Related]  

  • 32. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal metastasis from non-small-cell lung cancer initially detected by ¹⁸F-fluorodeoxyglucose positron emission tomography.
    Akamatsu H; Tsuya A; Kaira K; Nakamura Y; Naito T; Murakami H; Takahashi T; Endo M; Yamamoto N
    Jpn J Radiol; 2010 Nov; 28(9):684-7. PubMed ID: 21113753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
    Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.
    Li L; Hu M; Zhu H; Zhao W; Yang G; Yu J
    Clin Lung Cancer; 2010 Sep; 11(5):335-40. PubMed ID: 20837459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S; Bilfinger TV; Komaroff E; Franceschi D
    Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography.
    Obando JA; Samii JM; Yasrebi M
    Clin Nucl Med; 2008 Nov; 33(11):775-7. PubMed ID: 18936611
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In regard to Shusharina et al.
    Saraiya S; Hugo G; Weiss E
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):968-9. PubMed ID: 25585790
    [No Abstract]   [Full Text] [Related]  

  • 39. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G
    J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract]   [Full Text] [Related]  

  • 40. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
    Laking G; Price P
    Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.